Wednesday, July 8, 2026

Drug profile · INN

isosorbide

isosorbide (ISMOTIC) is a osmotic agent. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 2
Pipeline programs 2
News articles 0
Drug details — isosorbide
US status
approved
Class
Route
ORAL
Patents
2
Programs
2
Data quality
0.84

Quick answer

isosorbide (ISMOTIC) is a osmotic agent. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN isosorbide
Brand ISMOTIC
Mechanism Osmotic agent
Route ORAL
Formulation SOLUTION

Mechanism of action

Osmotic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Isosorbide Mononitrate Phase 2 · United Therapeutics Europe · Kidney Injury
  2. Isosorbide Dinitrate 5 MG Unknown · Chinese Academy of · Post-ERCP Acute Pancreatitis

Related patents

  1. US 10213389

    Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 9463166

    Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is isosorbide?

isosorbide (ISMOTIC) is a osmotic agent. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for isosorbide?

ISMOTIC is a marketed brand name for isosorbide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of isosorbide?

isosorbide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.